483 Sumitomo Dainippon Pharma Apr 2019

483 Sumitomo Dainippon Pharma Apr 2019

Linda Murphy FDA, Zhongren Wu FDA$119.00 - Available Now

FDA investigators audited the Sumitomo Dainippon Pharma - Oita, Japan facility and issued inspectional observations (via FDA 483) on 16 Apr 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Apr 2019
  • Location: Oita, Japan
  • FEI: 3005619533
Add To Cart